SEC Form 4 · accession 0001104659-16-128431
Aralez Pharmaceuticals Inc. · ARLZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
francis martin thrasher
Director
Period of report
Jun 16, 2016
Accepted (ET)
Jun 20, 2016 · 9:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660719
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par valueF2,F3 | Jun 16, 2016 | A | 7,500 | $0.00 | A | 11,865 | D | |
| Common Shares, without par valueF4 | holding | — | — | — | 272,813 | I | By 2089636 Ontario Ltd. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F5 | $3.42 | Jun 16, 2016 | A | 15,000 | A | — | Jun 16, 2026 | Common Shares, without par value | 15,000 | 15,000 | D |
Explanation of responses
- F1Restricted Stock Units, all of which vest on the earlier of June 16, 2017 or the date of the Company's next annual shareholder meeting, subject to the director's continued service on the Board as of such date.
- F2Includes 4,365 shares of Common Stock and 7,500 Restricted Stock Units.
- F3Due to a clerical error on the Reporting Person's Form 4, dated as of June 15, 2016, the amount of securities directly beneficially owned by the Reporting Person was incorrectly reported as 277,178 (which reflected the combined amount of securities directly and indirectly owned by the Reporting Person) rather than 4,365. This Form 4 reflects the correct amount of directly beneficially owned securities and indirectly owned securities, properly reported as separate line items.
- F4The Reporting Person is the sole owner and president of 2089636 Ontario Ltd.
- F5The option vests in one installment on the earlier of June 16, 2017 or the date of the Company's next annual shareholder meeting, subject to the director's continued service on the Board as of such date.